We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
2
0 active
Approvals
0
Total approvals
Agencies
Regulatory bodies
Founded
2005
Completed
100.0%
No approval data available
- LinusBio and Autism Speaks have partnered to promote ClearStrand-ASD, a first-in-class biochemical test that identifies autism biomarkers in hair strands of infants and toddlers aged 1-36 months. - The collaboration will integrate the diagnostic tool with Autism Speaks' Autism Response Team and upcoming Empower Summit events, while providing educational resources and reduced-cost testing for families in need. - Early diagnosis is critical for autism intervention, with ClearStrand-ASD offering healthcare providers a new screening option for children at elevated risk, including those born preterm or with siblings on the autism spectrum.
